Literature DB >> 500784

The time course of mandelic and phenylglyoxylic acid excretion in workers exposed to styrene under model conditions.

H K Wilson, J Cocker, C J Purnell, R H Brown, D Gompertz.   

Abstract

Urinary excretion of mandelic and phenylglyoxylic acids by two technicians building glass-reinforced plastic boats has been measured over a 7-day period. Peak excretion of both metabolites occurred several hours after the end of exposure. There was little relationship between urinary mandelic acid concentrations measured at the end of shift and the maximum excretion observed in samples collected after this time. It is suggested that sampling strategies devised to monitor workers exposed to styrene should reflect maximum excretion rates of urinary mandelic acid.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500784      PMCID: PMC1008571          DOI: 10.1136/oem.36.3.235

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  12 in total

1.  The metabolism of styrene oxide in the isolated perfused rat liver. Identification and quantitation of major metabolites.

Authors:  A J Ryan; J R Bend
Journal:  Drug Metab Dispos       Date:  1977 Jul-Aug       Impact factor: 3.922

2.  Human exposure to styrene. II. Quantitative and specific gaschromatographic analysis of urinary mandelic and phenylglyoxylic acids as an index of styrene exposure.

Authors:  M Guillemin; D Bauer
Journal:  Int Arch Occup Environ Health       Date:  1976-04-28       Impact factor: 3.015

3.  Urinary mandelic acid concentration after occupational exposure to styrene and its use as a biological exposure test.

Authors:  K Engström; H Härkönen; P Kalliokoski; J Rantanen
Journal:  Scand J Work Environ Health       Date:  1976-03       Impact factor: 5.024

4.  Measurement of personal exposure to 1,1,1-trichloroethane and trichloroethylene using an inexpensive sampling device and battery-operated pump.

Authors:  J H Simmons; I M Moss
Journal:  Ann Occup Hyg       Date:  1973-04

5.  A new method for determination of mandelic acid excretion at low level styrene exposure.

Authors:  A Slob
Journal:  Br J Ind Med       Date:  1973-10

6.  Biotransformation of ethyl benzene, styrene, and alpha-methylstyrene in man.

Authors:  Z Bardodej; E Bardodejova
Journal:  Am Ind Hyg Assoc J       Date:  1970 Mar-Apr

7.  The practical application of the Portion Diffusion Sampler for the measurement of time weighted average exposure to volatile organic substances in air.

Authors:  M Evans; M Molyneux; T Sharp; A Bailey; P Hollingdale-Smith
Journal:  Ann Occup Hyg       Date:  1977-12

8.  Simultaneous determination by gas chromatography of the major metabolites in urine of toluene, xylenes and styrene.

Authors:  P B Van Roosmalen; I Drummond
Journal:  Br J Ind Med       Date:  1978-02

9.  Evaluation of hippuric, phenylglyoxylic and mandelic acids in urine as indices of styrene exposure.

Authors:  M Ikeda; T Imamura; M Hayaskh; T Tabuchi; I Hara
Journal:  Int Arch Arbeitsmed       Date:  1974

10.  Metabolism and toxicity of styrene.

Authors:  K C Leibman
Journal:  Environ Health Perspect       Date:  1975-06       Impact factor: 9.031

View more
  4 in total

1.  Styrene exposure and biologic monitoring in FRP boat production plants.

Authors:  M Ikeda; A Koizumi; M Miyasaka; T Watanabe
Journal:  Int Arch Occup Environ Health       Date:  1982-02       Impact factor: 3.015

2.  Effect of alcohol on the kinetics of mandelic acid excretion in volunteers exposed to styrene vapour.

Authors:  H K Wilson; S M Robertson; H A Waldron; D Gompertz
Journal:  Br J Ind Med       Date:  1983-02

3.  Analysis and stability of phenylglyoxylic and mandelic acids in the urine of styrene-exposed people.

Authors:  H Kivistö; K Pekari; A Aitio
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

4.  Evaluation of low exposure to styrene. I. Absorption of styrene vapours by inhalation under experimental conditions.

Authors:  H Wieczorek; J K Piotrowski
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.